Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for sepsis and organ dysfunction in ICU patients
IRCT20180713040452N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of atorvastatin in sepsis (2 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: erythrocyte sedimentation rate, C-reactive protein and 11 more. Started Apr 2019; status: completed.
02
Drugs
atorvastatin
03
Conditions
sepsis
Beyond the preview
Go deeper on IRCT20180713040452N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180713040452N1.